⌘K

Login Start Free

Home/Filings/4/0001209191-23-049759

4//SEC Filing

Jalota Deepika 4

Accession 0001209191-23-049759

CIK 0001699382other

View on SEC.gov Company Profile

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:26 PM ET

Size

4.8 KB

Accession

0001209191-23-049759

Insider Transaction Report

Form 4

Period: 2023-09-15

PMV Pharmaceuticals, Inc.PMVP

Chief Development Officer

Transactions

Sale
Common Stock
2023-09-15$6.62/sh−4,104$27,168→ 29,946 total

Footnotes (1)

[F1]The reported shares were sold to cover the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PMV Pharmaceuticals, Inc.

CIK 0001699382

Entity typeother

Related Parties

1

filerCIK 0001825192

Filing Metadata

Form type: 4
Filed: Sep 17, 8:00 PM ET
Accepted: Sep 18, 4:26 PM ET
Size: 4.8 KB

View on SEC.gov